Genocea Biosciences Company
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Funding Status:
IPO
Total Funding:
470569774
Last Funding Type:
Post-IPO Equity
Industry:
Atrificial Vectors and Immune Cells
Estimated Revenue:
$10M to $50M
Founded Date:
2006-01-01
Last Funding Date:
2020-07-22
Headquarters:
Cambridge, Massachusetts, United States
Employee Number:
51-100
Investors Number:
13